Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Population-level diagnostic and radiation treatment trends of low-risk prostate cancer.

Created on 26 Oct 2026

Authors

Steven M Monda, Varshini Odayar, Maggie Yin, Rachel Tucker Gonzalez, Salvador Jaime-Casas, Karolyn M Hopfensperger, Danielle Kendrick, Melissa A Mietzel, Mazen Mislmani, Mark Zaki, Patrick W McLaughlin, Todd M Morgan, William C Jackson, Matthew J Schipper, David K Heimburger, Alex K Bryant, Lori J Pierce, Tudor Borza, Robert T Dess

Published in

Cancer. Volume 132. Issue 21. Nov 01, 2026.

Abstract

Overtreatment of low-risk prostate cancer (PC) undermines screening efforts. Active surveillance is preferred for low-risk PC, but declining treatment may reflect diagnostic or treatment-selection changes. We assessed diagnostic risk-group trends among localized PC and low-risk trends among radiation-treated patients since 2010.
We analyzed localized PC in Surveillance, Epidemiology, and End Results Program (SEER; 2010-2023); Veterans Affairs (VA; 2010-2024); and Michigan Radiation Oncology Quality Consortium (MROQC; 2021-2025). Low-risk PC was defined as grade group 1, prostate-specific antigen <10 ng/mL, and clinical stage ≤T2a. Diagnosis-based analyses described risk-group trends among all localized PC diagnoses in SEER and VA and treatment among low-risk patients. The primary outcome was the proportion of radiation-treated patients classified as low-risk, evaluated using logistic regression.
Among localized PC, low-risk disease at diagnosis declined from 28.8% to 24.0% in SEER and from 32.3% to 21.9% in VA. Among diagnosed low-risk patients, receipt of neither radiation nor prostatectomy increased from 33.6% to 83.4% in SEER and from 51.6% to 96.3% in VA. Among 207,196 patients treated with radiation for localized PC (170,213 SEER; 34,635 VA; and 2348 MROQC), the proportion with low-risk disease declined from 33.7% to 6.5% in SEER, from 22.9% to 2.0% in VA, and remained ≤4.2% in MROQC. Declines persisted after adjustment.
Since 2010, low-risk PC has become less common at diagnosis, whereas diagnosed low-risk patients increasingly avoid treatment. Radiation for low-risk PC has markedly declined, paralleling surgical trends and reflecting a nationwide shift toward active surveillance.

PMID:
42928983
Bibliographic data and abstract were imported from PubMed on 26 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 33
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement